Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock, including acquisitions of phantom units and holdings of employee stock options and restricted stock units.
Summary
- On September 4, 2024, John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 with the SEC.
- The filing reports changes in his beneficial ownership of H.B. Fuller stock.
- The reported transactions include the acquisition of 91.57 phantom units on August 30, 2024, at a price of $0.0000.
- Corkrean directly owns 47,187 shares of common stock.
- He also holds various employee stock options with different exercise prices and expiration dates, as well as restricted stock units that vest over time.
- The filing details the number of derivative securities beneficially owned following the reported transactions.
Sentiment
Score: 5
Explanation: This is a routine filing, so the sentiment is neutral. It simply reflects changes in ownership.
Positives
- The reporting person's continued holding of a significant number of shares and stock options could be interpreted as a sign of confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may be interested in the insider's transactions as an indicator of management's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of grant for employee stock option with an exercise price of $43.48, expiring on 05/17/2026. |
| 01/26/2018 | Date of grant for employee stock option with an exercise price of $50.1, expiring on 01/26/2027. |
| 01/25/2019 | Date of grant for employee stock option with an exercise price of $53.57, expiring on 01/25/2028. |
| 01/24/2020 | Date of grant for employee stock option with an exercise price of $45.05, expiring on 01/24/2029. |
| 01/24/2021 | Date of grant for employee stock option with an exercise price of $48.35, expiring on 01/24/2030. |
| 01/27/2022 | Date of grant for employee stock option with an exercise price of $51.89, expiring on 01/27/2031. |
| 01/24/2023 | Date of grant for employee stock option with an exercise price of $72.94, expiring on 01/24/2032, and the vesting start date for restricted stock units expiring on 01/24/2025. |
| 01/24/2024 | Date of grant for employee stock option with an exercise price of $68.17, expiring on 01/24/2033, and the vesting start date for restricted stock units expiring on 01/24/2026. |
| 01/26/2025 | Date of grant for employee stock option with an exercise price of $77.72, expiring on 01/26/2034, and the vesting start date for restricted stock units expiring on 01/26/2027. |
| 08/30/2024 | Date of transaction for the acquisition of phantom units. |
| 09/04/2024 | Date of filing of the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.